US biotech Grove Biopharma has secured $30 million in a series A round to move its lead program targeting advanced prostate ...

French pharma major Sanofi delivered a set of first-quarter financial results that seemed to satisfy markets Thursday, as its ...

Zurich-based biotech MetrioPharm has appointed Stephan Rietiker as chair of its board of directors, following a unanimous ...

Swiss pharma giant Roche (ROG: SIX) today reported that it achieved sales growth of 6% (7% in francs) to 15.4 billion francs ...

Bristol Myers Squibb (NYSE: BMY) beat Wall Street expectations in the first quarter of 2025, sending shares higher in early ...

US biopharma Novavax (Nasdaq: NVAX) closed 20% higher on Wednesday after announcing an update on its COVID-19 vaccine. The US ...

Denmark’s Zealand Pharma (CPH: ZEAL), a company focused on the discovery and development of innovative peptide-based ...

UK-based pharma company Indivior (LSE: INDV) saw it shares rose 5.3% to 738.50 pence in early trading today after it ...

Hong Kong-based biopharma company Akeso (HKEX: 9926) announced that its global first-in-class PD-1/VEGF bispecific antibody, ...

US pharma giant Merck & Co was trading nearly 1% lower during Thursday morning’s New York trading, after announcing its first-quarter financial results.

South Korea’s Samsung Bioepis today released its Second Quarter 2025 Biosimilar Market Report, which provides the second quarter 2025 Average Sales Price (ASP) and Wholesale Acquisition Cost (WAC) of ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Skyclarys (omaveloxolone), the first treatment ...